Dr. Kerfoot and his team set out to develop a Qstream specific solution for diabetes management designed to help patients with type 2 diabetes better control their glucose levels. They created a diabetes-specific Qstream challenge to reinforce type 2 diabetes self-management education utilizing push notifications and game mechanics to generate strong patient engagement and improve outcomes. A recent clinical study found that type 2 diabetes patients who were randomly assigned to use Qstream had significantly greater reductions in hemoglobin A1c (HbA1c), a common measure of long-term blood glucose control, than their counterparts who received the identical content in a booklet format.
When Ascensia launched the diabetes challenge in late 2017, it received 116 submissions from entrepreneurs and start-ups around the world offering a range of digital solutions with the potential to revolutionize type 2 diabetes management.
Qstream was selected as one of six finalists by a panel consisting of external experts and members of the Ascensia Medical, R&D and Commercial teams.
On June 22nd, in conjunction with the American Diabetes Association’s 78th Scientific Sessions in Orlando, Florida, Ascensia announced the winning solutions, and we are thrilled that the judges in this challenge recognized the value of Qstream’s proven ability to help people with type 2 diabetes better manage glucose levels. Qstream CEO, Rich Lanchantin, was on hand with the team from Ascensia and the other challenge winners in Orlando, where the prizes were officially awarded.
To learn more about Qstream and how brain science is being used by leading medical centers, teaching schools and CME providers around the globe to reinforce education and influence behavior change, watch this webinar.